Results 181 to 190 of about 52,668 (245)

Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome: An international survey of current practice

British Journal of Haematology, Volume 208, Issue 3, Page 981-991, March 2026.
Summary Febrile neutropenia causes substantial morbidity in acute myeloid leukaemia and higher risk myelodysplastic syndrome. We aimed to describe current practice and priorities for clinical trials in the prevention and management of febrile neutropenia across Australia/New Zealand (ANZ), the United Kingdom (UK), Canada and Europe.
Aleece MacPhail, Justin Loke, Brett L. Houston, Claire Dendle, Andrea S. Henden, Robert Weinkove, Orla Morrissey, Dionysios Neofytos, Niccolò Buetti, Catriona Parker, Monica A. Slavin, Charles Craddock, Simon J. Stanworth, Zoe McQuilten, on behalf of the Australasian Leukaemia and Lymphoma Group Supportive Care Working Group and UK AML/Supportive Care Working Parties   +14 more
wiley   +1 more source

Burkholderia pseudomallei PenI β-lactamase and variants are potently inhibited by taniborbactam. [PDF]

Antimicrob Agents Chemother
Mojica MF, Becka SA, Edwards M, Myers C, Uehara K, Uehara T, Hoshino T, Zeiser ET, Chatwin CL, Six DA, Bonomo RA, Papp-Wallace KM, Nukaga M.   +12 more
europepmc   +1 more source

Shifting Antimicrobial Susceptibility Patterns of Uropathogens: A 20‐Year Analysis of Urine Cultures

International Journal of Urology, Volume 33, Issue 3, March 2026.
ABSTRACT Objectives Antimicrobial resistance among uropathogens, particularly extended‐spectrum β‐lactamase (ESBL) production and fluoroquinolone (FQ) resistance, presents a significant challenge to treating urinary tract infections (UTIs). This study aimed to analyze 20‐year trends in antimicrobial susceptibility among key urinary isolates at a single
Shinichi Takebe, Masami Endo, Nanaho Demizu, Mei Tokumoto, Ryota Morinaga, Taku Mitome, Akitoshi Takizawa   +6 more
wiley   +1 more source

Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Karunanidhi A, Singh N, Watkins JV, Smith NM, Zang Y, Shan X, Espinoza G, Li J, Lang Y, Bulitta JB, Bulman ZP.   +10 more
europepmc   +1 more source

Exploration of the Therapeutic Protocols and Underlying Molecular Mechanisms of Autologous Platelet‐Rich Plasma in the Treatment of Deep Second‐Degree Burns

Journal of Cosmetic Dermatology, Volume 25, Issue 3, March 2026.
ABSTRACT Background Platelet‐rich plasma (PRP) has been widely applied in burn wound management due to its high concentration of bioactive growth factors. However, inconsistent clinical outcomes and the lack of standardized protocols regarding timing, frequency, and leukocyte content limit its broader clinical adoption.
Jian‐Guo Shi, Wei Liu, Hong‐Qiang Liu, Dan Rao, Jun‐Wei Huang, Yu‐Fei Zhao   +5 more
wiley   +1 more source

Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant <i>Enterobacterales</i>. [PDF]

Microbiol Spectr
Meng Q, Xu C, Li W, Shen K, Huang X, Fu X, Zhou L, Chen Y, Hu F, Wang H.   +9 more
europepmc   +1 more source

Repurposing Drugs as Bacteroides fragilis BFT‐3 Inhibitors in the Animal Infection Model Galleria mellonella

Annals of the New York Academy of Sciences, Volume 1557, Issue 1, March 2026.
This work establishes a newly developed Galleria mellonella infection model as a powerful, ethical platform for studying Bacteroides fragilis pathogenesis and therapy. Leveraging this model, the study identifies MOA4 as a potent BFT‐3 inhibitor that improves host survival, increases bacterial clearance, and synergizes with antibiotics without toxicity.
Ana Jiménez‐Alesanco, Marta Gómara‐Lomero, Hajar Jeblaoui, Sonia Vega, Adrián Velázquez‐Campoy, José Antonio Aínsa, Olga Abián   +6 more
wiley   +1 more source

Antibacterial Potential of Actinomycete Extracts and Characterization of β-Lactamase-Producing Multidrug-Resistant Uropathogenic Escherichia coli. [PDF]

Microbiologyopen
Khaledi H, Obeid NO.
europepmc   +1 more source

Fluorescent proteins: A journey from the cell to extreme environments in material science

Photochemistry and Photobiology, Volume 102, Issue 2, Page 290-302, March/April 2026.
Applications of proteins and microorganisms as tools or effectors in material science. Abstract This review presents the progression from the use of fluorescent proteins (FPs) and chromoproteins as bioimaging labels and sensors to the strategic engineering of their properties for robust functionality in synthetic and non‐biological environments ...
Bianca Menchicchi, Andre C. Stiel, Mattia Nieddu, J. P. Fuenzalida‐Werner   +3 more
wiley   +1 more source

Variations in carbapenem resistance associated with the VIM-1 metallo-β-lactamase across the <i>Enterobacterales</i>. [PDF]

Microbiology (Reading)
Rondinelli M, Kaur S, Ledwell OA, Wong H, Sheth PM, diCenzo GC.   +5 more
europepmc   +1 more source